Dr. Amit Gupta, MD, FACS, Ophthalmologist, talks about safety and the low risks associated with intravitreal injections. Mike Johnson Shifts Tone On Health Care As Shutdown Drags On Tim Curry’s wry ...
A retrospective case series suggested that faricimab (Vabysmo) intravitreal injections may be associated with rare cases of noninfectious intraocular inflammation. Over a 22-month period, 12 eyes from ...
In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended. Christina Y. Weng, MD, MBA, and colleagues compared the intended ...
A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results